Community-acquired pneumonia in immunocompromised older patients: Incidence, causative organisms and outcome

Clinical Microbiology and Infection

Volumn 19, Issue 2, 2013, Pages 187-192

  Sousa, D ^a   Justo, I ^a   Dominguez A ^b,c   Manzur, A ^d   Izquierdo, C ^e   Ruiz, L ^e   Nebot, M ^c,f   Bayas, J M ^g   Celorrio, J M ^h   Varona, W ⁱ   Llinares, P ^a   Miguez, E ^a   Sanchez E ^a   Carratala J ^d  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e Generalitat of Catalonia ^*  (Spain)

^f AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h Hospital Ernest Lluch   (Spain)

ⁱ HOSPITAL ROYO VILLANOVA   (Spain)

Author keywords

CAP; Community acquired pneumonia; Elderly; Immunocompromised; Immunosuppression

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTINEOPLASTIC AGENT; AZITHROMYCIN; CEFTRIAXONE; CORTICOSTEROID; CYTOSTATIC AGENT; IMMUNOSUPPRESSIVE AGENT; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL PNEUMONIA; CANCER PATIENT; COMBINATION CHEMOTHERAPY; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FATALITY; FEMALE; GRAFT RECIPIENT; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INTENSIVE CARE UNIT; LEGIONELLA; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NOCARDIA; NOCARDIOSIS; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; PUBLIC HOSPITAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SOLID TUMOR; SPAIN; STEM CELL TRANSPLANTATION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VIRUS PNEUMONIA;

BACILLI (CLASS); LEGIONELLA PNEUMOPHILA; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE;

EID: 84873523976     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03765.x     Document Type: Article

References (27)

1. Fernandez-Sabe N, Carratala J, Roson B et al. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore) 2003; 82: 159-169.
2. Almirall J, Mesalles E, Klamburg J, Parra O, Agudo A. Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest 1995; 107: 511-516.
3. Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Raga-Luria X, Gomez-Bertomeu F. Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med 2009; 103: 309-316.
4. Mandell LA, Wunderink RG, Anzueto A et al. Infectious diseases society of america/american thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (suppl 2): S27-S72.
5. Fine MJ, Auble T, Yealy D, Hanusa B, Weissfeld L, Singer DE. A prediction rule to identify low-risk patients with community-acquired pneumonia. NEJM 1997; 336: 243-250.
6. Carratala J, Mykietiuk A, Fernandez-Sabe N et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167: 1393-1399.
7. Domínguez A, Izquierdo C, Salleras L et al. Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly. Eur Respir J 2010; 36: 608-614.
8. Loeb M, Neupane B, Walter S et al. Environmental risk factors for community-acquired pneumonia hospitalization in older adults. JAGS 2009; 57: 1036-1040.
9. Mundy LM, Auwaerter PG, Oldach D et al. Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 1995; 152: 1309-1315.
10. Jacobson KL, Miceli MH, Tarrand JJ, Kontoyiannis DP. Legionella pneumonia in cancer patients. Medicine (Baltimore) 2008; 87: 152-159.
11. Camps Serra M, Cervera C, Pumarola T et al. Virological diagnosis in community-acquired pneumonia in immunocompromised patients. Eur Respir J 2008; 31: 618-624.
12. Youssef S, Rodriguez G, Rolston KV, Champlin RE, Raad II, Safdar A. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005. Medicine (Baltimore) 2007; 86: 69-77.
13. Sanders KM, Marras TK, Chan CK. Pneumonia severity index in the immunocompromised. Can Respir J 2006; 13: 89-93.
14. File T. Community-acquired pneumonia. Lancet 2003; 362: 1991-2001.
15. Fine MJ, Stone RA, Singer DE et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team (PORT) cohort study. Arch Intern Med 1999; 159: 970-980.
16. Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff K. Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 2008; 32: 139-146.
17. Donowitz G, Cox H. Bacterial community-acquired pneumonia in older patients. Clin Geriatr Med 2007; 23: 515-534, vi.
18. Kaplan V, Angus D, Griffin M, Clermont G, Watson RS, Linde-Zwirble W. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the united states. Am J Respir Crit Care Med 2002; 165: 766-772.
19. Fernandez Aviles F, Batlle M, Ribera JM et al. [pneumonias in patients with malignant hemopathies. Their etiology, response to treatment and prognostic factors in 69 patients (88 episodes)]. Med Clin (Barc) 1999; 112: 321-325.
20. de Roux A, Ewig S, Garca E et al. Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J 2006; 27: 795-800.
21. Fernandez Guerrero ML, Ramos JM, Marrero J, Cuenca M, Fernandez Roblas R, de Gorgolas M. Bacteremic pneumococcal infections in immunocompromised patients without aids: the impact of beta-lactam resistance on mortality. Intern J Infect Dis 2003; 7: 46-52.
22. Lenner R, Padilla ML, Teirstein AS, Gass A, Schilero GJ. Pulmonary complications in cardiac transplant recipients. Chest 2001; 120: 508-513.
23. von Baum H, Welte T, Marre R, Suttorp N, Ewig S. Community-acquired pneumonia through enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors. Eur Respir J 2010; 35: 598-605.
24. Micek S, Kollef K, Reichley R, Roubinian N, Kollef M. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007; 51: 3568-3573.
25. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care associated pneumonia: results from a large us database of culture-positive pneumonia. Chest 2005; 128: 3854-3862.
26. Hidron A, Low C, Honig E, Blumberg H. Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain usa300 as a cause of necrotising community-onset pneumonia. Lancet Infect Dis 2009; 9: 384-392.
27. Ruhnke G, Coca-Perraillon M, Kitch B, Cutler D. Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia. Am J Med 2011; 124: 171-178.e171.